期刊文献+

裸鼠胰腺癌USPIO和MSLN-USPIO的MR成像对照研究 被引量:1

MR study with USPIO and MSLN-USPIO in the nude mouse model bearing human pancreatic carcinoma
原文传递
导出
摘要 目的 研究利用隐形纳米脂质体包裹的Mesothelin抗体修饰的超小超顺磁性氧化铁(MSLN-USPIO)作MRI靶向对比剂诊断裸鼠皮下种植胰腺癌的可能性和价值.方法 制作多时间节点荷人胰腺癌裸鼠模型,分别使用USPIO和MSLN-USPIO作为MRI对比剂进行3.0T MRI扫描,比较二者对最小种植瘤的显示阳性率、种植瘤组织T2WI的负性强化率;通过种植瘤标本普鲁士蓝染色,观察种植瘤组织中铁离子沉积.结果 两种对比剂显示最小肿瘤的阳性率差异无统计学意义;使用USPIO增强后左、右腋窝肿瘤的负性强化率分别为(12.29±7.45)%和(11.06±5.91)%,使用MSLN-USPIO增强后左、右腋窝肿瘤的负性强化率分别为(33.88±6.09)%和(43.29±11.64)%,两组种植瘤增强前后的信号值差异及同一部位种植瘤增强后的负性强化率差异均有统计学意义(P值均<0.05),且MSLN-USPIO组的负性强化率显著高于USPIO组(P<0.05).普鲁士蓝染色显示MSLN-USPIO组种植瘤组织内的铁颗粒沉积明显多于USPIO组.结论 MSLN-USPIO的增强效果明显优于USPIO,可作为荷瘤裸小鼠胰腺癌MRI靶向对比剂。 Objective To study the potential and value of ultrasmall superparamagnetic iron oxide (USPIO) conjugated by mesothelin antibody as MRI targeting contrast agent for diagnosis of implanted human pancreatic carcinomas in nude mouse.Methods Nude mouse tumor models bearing multiple human pancreatic carcinomas at different time points was established and they were randomized into two groups,and USPIO or MSLN-USPIO were used as contrast enhanced agents in the 3.0T MRI scan,respectively,then the positive detection rates for smallest tumors,and the signal intensity of tumors in T2 mapping images of both unenhanced and contrast enhanced scanning and the negative enhancement rate were measured,then Prussian blue staining was performed in alI the tumor specimens to observe the difference of Fe3 + ion deposition.Results There was no statistical significance between USPIO group and MSLN-USPIO group in the positive detection rates for smallest tumors.In USPIO group,the negative enhancement rate of left or right axilla tumors was (12.29 ±7.45)% and (11.06 ±5.91)%,and they were (33.88 ±6.09)% and (43.29 ± 11.64)% in MSLN-USPIO group.There was statistical significance in the difference of signal intensity between unenhanced and contrast enhanced in left or right axilla tumors (P 〈 0.05),and the negative enhancement rate in MSLN-USPIO group was significantly higher than that in USPIO group (P 〈0.05).The Fe^3+ ion deposition in tumors' tissue in MSLN-USPIO group was significantly more than that in USPIO group.Conclusions The enhanced effect of MSLN-USPIO is superior to USOPIO,and it can be a tumor targeted MR contrast enhanced agent for the diagnosis of pancreatic carcinoma in nude mouse.
出处 《中华胰腺病杂志》 CAS 2015年第3期177-181,共5页 Chinese Journal of Pancreatology
基金 国家自然科学基金资助项目(30970801)
关键词 胰腺肿瘤 超微超顺磁性氧化铁 小鼠 磁共振成像 Pancreatic neoplasm Ultrasmall superparamagnetic iron oxide Mice,nude Magnetic resonance imaging
  • 相关文献

参考文献10

  • 1Gupta H, Weissleder R. Targeted contrast agents in MR imaging [J]. Magn Resort hnagingClin N Am, 1996,4(1):171-184.
  • 2Atri M. New technologies and directed agents fbr applications of cancer imaging[ J ]. J Clin Oneol, 2006,24 (20) :3299-3308.
  • 3Barrett T, Kobayashi H, BrechbieL M, et al. Macromolecular MRI contrast agents |'or imaging tumor angiogenesis [ J ]. Eur J Radiol, 2006,60( 3 ) :353-366.
  • 4吕国士,许乙凯.脂质体MRI对比剂的研究进展[J].国外医学(临床放射学分册),2006,29(1):1-4. 被引量:3
  • 5姜庆军,刘士远,肖湘生.MRI靶向对比剂载体的研究近况[J].临床放射学杂志,2003,22(9):801-803. 被引量:2
  • 6Park YS. Tumor-directed targeting of liposomes[ J]. Biosci Rep, 2002,22 (2):267-281.
  • 7潘璜,吴洪玉,陈士跃,刘敬禹,邵成伟,田建明.三种胰腺癌细胞株Mesothelin的表达及成瘤速度的比较[J].中华胰腺病杂志,2012,12(5):326-328. 被引量:1
  • 8Deng Li, Ke X, He Z, et al. A MSLN-targeted muhifunctional nanoimmunoliposome for MRI and targeting therapy in pancreaticcancer[ J]. Int J Nanomedicine, 2012,7 : 5053-5065.
  • 9潘璜,邵成伟,田建明.多时间节点荷人胰腺癌SW1990细胞裸鼠模型的建立及其MRI表现[J].中华胰腺病杂志,2012,12(2):123-125. 被引量:2
  • 10Anderson SA, Rader RK, Westlin WF, et al. Magnetic resonance contrast enhancement of neovasculature with alpha (v) beta(3 ) -targeted nanoparticles [ J ]. Magn Resort Med, 2000,44 (3) :433-439.

二级参考文献67

  • 1叶燕丽,周昕熙,王莲桂.裸小鼠的繁殖及在肿瘤学中的应用[J].实验动物科学与管理,2005,22(1):6-8. 被引量:16
  • 2朱庆云,屠振兴,李兆申,满晓华.Mesothelin在胰腺癌组织的表达及其临床意义[J].胰腺病学,2005,5(1):17-20. 被引量:8
  • 3Ikezaki K, Nomura T, Takahashi M,et al. Selective and prolonged MRI enhancement by Mn-TPPS in an experimental rat brain tumour with peripheral benzodiazepine receptors. Neurol-Res, 1994, 16:393.
  • 4Kresse M, Wagner S, Pfefferer D, et al. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn-Reson-Med, 1998, 40:236.
  • 5Small WC, Nelson RC, Sherbourne GM, et al. Enhancement effects of a hepatocyte receptor-specific MR contrast agent in an animal model. J-Magn-Reson-Imaging, 1994, 4:325.
  • 6Tatsushi S, Soji O, Masakazu U, et al. Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody. Int J Cancer, 1998, 626.
  • 7Anderson SA, Fader RK, West]in WF, et al. Magnetic resonance con-trast enhancement of neovasculature with alpha (v) beta (3)-targetednanoparticles. Magn-Reson-Med, 2000, 44:433.
  • 8Sipkins DA, Cheresh DA, Kazemi M/R, et 81. Detection of tumor an-giogenesis in vivo by alpha Vbeta3-targeted magnetic resonance imaging.Nat-Med, 1998, 4:623.
  • 9Peter reimer et al. Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging. Radiology, 1994, 193:527.
  • 10Shen TT, Bogdanov Ajr, Bogdanova A, et al. Magnetically labeled secretin retains receptor affinity to pancreas acinar cells. Biceonjug-Chem,1996. 7:311.

共引文献3

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部